semaglutide shortage 2025 fda resolved feb 21 As of February 21, 2025, the updated its drug semaglutide shortage 2025 The Is

Tirzepatide versus semaglutide: the core difference Semaglutide (Ozempic, Wegovy, and compounded versions) targets GLP-1 receptors only

This review systematically evaluates the clinical evidence regarding the association between semaglutide use and acid reflux, providing insights into its prevalence, mechanisms, and management strategies

Eligibility for the Medicare GLP-1 Bridge will also be limited to Medicare beneficiaries who have not filled a prescription under their Part D plan for a GLP-1 in 2026, and who do not have a diagnosis with a condition that is a medically accepted indication for a GLP-1 drug that could be covered under Part D (specified by CMS as type 2 diabetes, obstructive sleep apnea (OSA), and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH)), even if they otherwise meet the clinical criteria

Reduced hepatic expression of glutathione s-transferases in burned mice

Automated alerts flag potential issues early such as rapid weight loss or lack of weight change so clinicians can intervene sooner rather than later